Physician profile
Weihan Chen
NPI 1447788179
$51,328.41
in general payments reported to CMS, 2019-2025
14 companies · $48K in 2025
The $48K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.49 · 2024: $3,123 · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $48K · Food and Beverage: $3,036 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $48,071.00 |
| Food and Beverage | $3,036.17 |
| Education | $221.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,989.29 | 2025 | Mitraclip, Navitor |
| Medtronic, INC. | $16,599.98 | 2023-2025 | Onyx Frontier, Corevalve Evolut R, Ffrangio |
| Boston Scientific Corporation | $15,177.36 | 2024-2025 | General - Structural Heart, Watchman Flx, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $1,623.84 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Abiomed | $374.62 | 2024-2025 | Impella |
| Penumbra, INC. | $166.99 | 2025 | Indigo System |
| Inari Medical, INC. | $112.64 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.26 | 2024-2025 | Lifevest |
| Janssen Scientific Affairs, LLC | $42.06 | 2024 | Xarelto |
| Cathworks, INC. | $41.35 | 2025 | Ffrangio |
| Janssen Pharmaceuticals, INC | $33.05 | 2024 | Xarelto |
| Stryker Corporation | $22.42 | 2025 | Flowtriever |
| E.R. Squibb & Sons, L.L.C. | $20.10 | 2025 | Camzyos |
| Pfizer INC. | $15.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weihan Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.